Vident Investment Advisory’s United Therapeutics UTHR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,698	Closed	-$596K	–	1018
2023 Q2	$596K	Buy	2,698 +1,267	+89%	+$281K	0.02%	630
2023 Q1	$320K	Sell	1,431 -540	-27%	-$133K	0.01%	930
2022 Q4	$548K	Sell	1,971 -9,793	-83%	-$2.47M	0.02%	678
2022 Q3	$2.33M	Buy	11,764 +10,829	+1,158%	+$2.42M	0.08%	289
2022 Q2	$214K	Buy	+935	New	+$190K	0.01%	1111
2018 Q3	–	Sell	-2,051	Closed	-$232K	–	1008
2018 Q2	$232K	Buy	2,051 +254	+14%	+$27.9K	0.01%	852
2018 Q1	$202K	Buy	1,797 +150	+9%	+$19.1K	0.01%	870
2017 Q4	$244K	Buy	+1,647	New	+$209K	0.01%	735
2017 Q3	–	Sell	-17,949	Closed	-$2.33M	–	775
2017 Q2	$2.33M	Buy	17,949 +497	+3%	+$62K	0.19%	202
2017 Q1	$2.36M	Buy	+17,452	New	+$2.64M	0.23%	188
2015 Q4	–	Sell	-12,993	Closed	-$1.71M	–	827
2015 Q3	$1.71M	Buy	12,993 +2,645	+26%	+$424K	0.24%	117
2015 Q2	$1.8M	Buy	10,348 +1,410	+16%	+$254K	0.24%	108
2015 Q1	$1.54M	Buy	8,938 +4,108	+85%	+$626K	0.31%	39
2014 Q4	$625K	Buy	+4,830	New	+$622K	0.21%	155